Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1284400

	registered interest
	date	05/02/2021
	answering body	Foreign, Commonwealth and Development Office
	answering dept id	208
	answering dept short name	Foreign, Commonwealth and Development Office
	answering dept sort name	Foreign, Commonwealth and Development Office
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, if the Government will take steps to use its Presidency of the G7 to propose support for (a) the WHO COVID-19 Technology Access Pool and (b) increasing Official Development Assistance funding to scale-up vaccine manufacturing capacity in low and middle income countries.
	tabling member constituency	Norwich South
	tabling member printed	Clive Lewis
	uin	149803
	answer	answer is ministerial correction date of answer 12/02/2021 answer text <p>The UK will champion rapid equitable access to safe and effective vaccines throughout our G7 Presidency.</p><p>Since the World Health Organisation (WHO) provided initial details on the COVID-19 technology access pool (C-TAP) in October, the UK has led the way in bringing industry and the research community to the table. During our G7 presidency, we will continue this work with stakeholders and the WHO as it establishes the governance structures and refines the operating model for C-TAP.</p><p>The FCDO is working closely with key development partners in vaccines, such as the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccines Alliance, WHO and the United Nations International Children's Emergency Fund (UNICEF), along with development finance institutions and the private sector to catalyse investments for vaccine manufacturing in Africa.</p> answering member constituency Aldridge-Brownhills answering member printed Wendy Morton question first answered 12/02/2021 11:48:39 answering member 4358 label Biography information for Wendy Morton
	tabling member	4500 label Biography information for Clive Lewis

1284397

	registered interest
	date	05/02/2021
	answering body	Foreign, Commonwealth and Development Office
	answering dept id	208
	answering dept short name	Foreign, Commonwealth and Development Office
	answering dept sort name	Foreign, Commonwealth and Development Office
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment the Government has made of the effect on global equality of access to the covid-19 vaccines in the event that the proposed WTO TRIPS Waiver is not adopted.
	tabling member constituency	Norwich South
	tabling member printed	Clive Lewis
	uin	149801
	answer	answer is ministerial correction date of answer 15/02/2021 answer text <p>The UK is committed to rapid equitable access to safe and effective vaccines, and is playing a leading role in financing the global effort, and identifying solutions that ensure affordable access for all.</p><p>The UK Government does not consider waiving intellectual property (IP) rights to be an appropriate course of action in boosting the manufacturing of safe, effective, and quality vaccines. The existing intellectual property framework has mobilised research and development to deliver a host of new medicines and technologies to detect, treat, and defend against COVID-19. The incentives and access mechanisms provided by the IP framework have been integral to this success, without which we would not have seen the impressive surge of research and development, and the unprecedented scaling up of production.</p> answering member constituency Aldridge-Brownhills answering member printed Wendy Morton question first answered 15/02/2021 09:33:49 answering member 4358 label Biography information for Wendy Morton
	tabling member	4500 label Biography information for Clive Lewis